Objective: The objective of this study was to examine the relationship between the rate of bilirubin decrease following preoperative biliary drainage before pancreaticoduodenectomy and postoperative morbidity. Methods: Records of patients who underwent pancreaticoduodenectomy at the Department of Surgery in Ramathibodi Hospital between January 2008 and December 2019 were retrospectively reviewed. The patients were classified into either an adequate or inadequate drainage rate groups according to the bilirubin decrease rate. Major morbidity was defined as higher than grade II in the Clavien-Dindo classification. Risk factors for major morbidity were analyzed by logistic regression analysis. Results: In total, 166 patients were included in the study. Major morbidity was observed in 36 patients (21.6%). Adequate biliary drainage rate was observed in 39 patients (23.4%). Patients who had major morbidity were less likely to have come from the adequate biliary drainage rate group than the inadequate group (38.9% vs. 61.1%). However, through multivariate logistic analysis, only body mass index, operative time, and pancreatic duct diameter were independent factors associated with major morbidity, whereas the bilirubin decrease rate was not. Conclusions: Bilirubin decrease rate following preoperative biliary drainage has no significant association with major postoperative morbidity after pancreaticoduodenectomy.
Background: Management of isolated free fluid following blunt abdominal injury in hemodynamically stable patients is still controversial with respect to nonoperative management (NOM) versus immediate laparotomy. This meta-analysis was performed to identify significant intra-abdominal injuries that require therapeutic laparotomy, thus helping in decision-making during initial management. Method: We systematically reviewed the PubMed and SCOPUS databases from 2000 to 2020. The primary outcome of interest was identification of significant intra-abdominal injuries requiring therapeutic laparotomy. We performed the meta-analysis using a random-effects model. Results: Eight studies involving 7763 patients were evaluated. Isolated free fluid was present in 722 (9.3%) patients. Their median age was 35.82 years, and their average Injury Severity Score was 17.1. The major mechanism of injury was motor vehicle accidents (31.2%). Of 722 patients, 490 underwent initial NOM and 232 underwent immediate laparotomy. The success rate of initial NOM was 98% [95% confidence interval (CI), 0.959–1.002]. The failure rate of initial NOM was 7.4% (95% CI, 0.023–0.126). Significant intra-abdominal injuries were identified in 39.2% of patients (95% CI, 0.127–0.657). Most of the significant intra-abdominal organ injuries were mesenteric injury in 23% of patients (95% CI, −0.004–0.463) and bowel injury in 18.4% (95% CI, 0.098–0.271). A moderate to large amount of fluid on computed tomography and abdominal tenderness were associated with laparotomy (p = 0.000 and 0.040, respectively), but neither was a significant risk factor for therapeutic laparotomy or significant intra-abdominal injury. Conclusions: Isolated free fluid following blunt abdominal injury in hemodynamically stable patients does not mandate immediate or delayed laparotomy. Initial NOM can be considered with hemodynamic monitoring of early warning signs of sepsis (e.g., using the Quick Sequential Organ Failure Assessment), and serial abdominal examination might help to detect significant intra-abdominal injury requiring therapeutic laparotomy. In patients suspected to have injury after initial NOM and in patients who cannot cooperate, diagnostic laparoscopy will play an important role in minimally invasive diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.